The company’s lead candidate, GLY-200, is advancing into phase 2 clinical studies for the treatment of type 2 diabetes. The gastrointestinal (GI) tract is a major player in metabolic regulation ...
This new article publication from Acta Pharmaceutica Sinica B , discusses how SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites. Viruses often ...